Cargando…

Leptin, IL-6, and suPAR reflect distinct inflammatory changes associated with adiposity, lipodystrophy and low muscle mass in HIV-infected patients and controls

BACKGROUND: HIV-infected patients could exhibit accelerated ageing, since age-associated complications like sarcopenia; increased inflammation; lipodystrophy with loss of subcutaneous adipose tissue and/or gain of visceral adipose tissue (VAT); and cardiovascular disease occur at an earlier age. Inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langkilde, Anne, Petersen, Janne, Henriksen, Jens Henrik, Jensen, Frank Krieger, Gerstoft, Jan, Eugen-Olsen, Jesper, Andersen, Ove
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523999/ https://www.ncbi.nlm.nih.gov/pubmed/26244048 http://dx.doi.org/10.1186/s12979-015-0036-x

Ejemplares similares

suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)

Healthy lifestyles reduce suPAR and mortality in a Danish general population study
por: Haupt, Thomas Huneck, et al.
Publicado: (2019)

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study
por: Haupt, Thomas Huneck, et al.
Publicado: (2012)

SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015)

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
por: Iversen, Esben, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2021)

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19
por: Altintas, Izzet, et al.
Publicado: (2021)

High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)

Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment
por: Rabna, Paulo, et al.
Publicado: (2012)

The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
por: Håkansson, K. E. J., et al.
Publicado: (2019)

suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department
por: Santeri, Seppälä, et al.
Publicado: (2021)

suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis
por: Hodges, Gethin W, et al.
Publicado: (2018)

Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
por: Höybye, Charlotte, et al.
Publicado: (2019)

suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022)

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study*
por: Rasmussen, Line J. H., et al.
Publicado: (2018)

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department
por: Walls, Anne Byriel, et al.
Publicado: (2021)

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2016)

Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2020)

suPAR as a prognostic biomarker in sepsis
por: Donadello, Katia, et al.
Publicado: (2012)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

suPAR to Risk-Stratify Patients With Malaria
por: Stefanova, Veselina, et al.
Publicado: (2022)

Inflammation in HIV-Infected Patients: Impact of HIV, Lifestyle, Body Composition, and Demography – A Cross Sectional Cohort Study
por: Langkilde, Anne, et al.
Publicado: (2012)

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
por: Meyer, Jeppe, et al.
Publicado: (2018)

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
por: Rovina, Nikoletta, et al.
Publicado: (2020)

Immunosenescence of the CD8(+) T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls
por: Tavenier, Juliette, et al.
Publicado: (2015)

suPAR, a Circulating Kidney Disease Factor
por: Wei, Changli, et al.
Publicado: (2021)

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes
por: Haupt, T.H., et al.
Publicado: (2023)

Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial
por: Schultz, Martin, et al.
Publicado: (2019)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2017)

suPARnostic(® )as a treatment efficacy monitoring tool in systemic inflammatory response syndrome/sepsis patients
por: Eugen-Olsen, Jesper, et al.
Publicado: (2008)

Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV‐1‐infected patients: a nested case‐control study
por: Rasmussen, LJH, et al.
Publicado: (2015)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
por: Rabensteiner, Jasmin, et al.
Publicado: (2016)

suPAR Surprises as a Biomarker of Invasive Outcomes in Pleural Infection
por: Idell, Steven, et al.
Publicado: (2020)

The Perspective of Vitamin D on suPAR-Related AKI in COVID-19
por: Liao, Tzu-Hsien, et al.
Publicado: (2022)

The Association of suPAR with Cardiovascular Risk Factors in Young and Healthy Adults
por: Wohlwend, Niklas Fabio, et al.
Publicado: (2023)

suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury
por: Nusshag, Christian, et al.
Publicado: (2023)

SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study
por: Polzik, Peter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l358un7hpu5i1ee12o607poblf